Clinical outcome of gastric cancer patients with bone marrow metastases

Cancer Research and Treatment

Volumn 43, Issue 4, 2011, Pages 244-249

  Kwon, Ji Yeon ^a   Yun, Jina ^a   Kim, Han Jo ^b   Kim, Kyoung Ha ^a   Kim, Se Hyung ^a   Lee, Sang Cheol ^a   Kim, Hyun Jung ^b   Bae, Sang Byung ^b   Kim, Chan Kyu ^a   Lee, Nam Su ^a   Lee, Kyu Taek ^b   Park, Seong Kyu ^a   Won, Jong Ho ^a   Hong, Dae Sik ^a   Park, Hee Sook ^a  

^a Soonchunhyang University College of Medicine   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Bone marrow; Drug therapy; Neoplasm metastasis; Stomach neoplasms

Indexed keywords

EID: 84859821498     PISSN: 15982998     EISSN: 20059256     Source Type: Journal    
DOI: 10.4143/crt.2011.43.4.244     Document Type: Article

References (11)

1. Shin HR, Jung KW, Won YJ, Park JG; 139 KCCR-affiliated Hospitals. 2002 annual report of the Korea Central Cancer Registry: based on registered data from 139 hospitals. Cancer Res Treat. 2004;36:103-14.
2. Crivellari D, Carbone A, Sigon R, Buonadonna A, Cannizzaro R, Sorio R, et al. Gastric cancer with bone marrow invasion at presentation: case-report and review of the literature. Tumori. 1995;81:74-6.
3. Noda N, Sano T, Shirao K, Ono H, Katai H, Sasako M, et al. A case of bone marrow recurrence from gastric carcinoma after a nine-year disease-free interval. Jpn J Clin Oncol. 1996;26:472-5.
4. Hayes DF. Prognostic and predictive factors revisited. Breast. 2005;14:493-9.
5. Kobayashi M, Okabayashi T, Sano T, Araki K. Metastatic bone cancer as a recurrence of early gastric cancer: characteristics and possible mechanisms. World J Gastroenterol. 2005;11: 5587-91.
6. Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist H, et al. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. J Clin Oncol. 2003;21:3469-78.
7. Kusumoto H, Haraguchi M, Nozuka Y, Oda Y, Tsuneyoshi M, Iguchi H. Characteristic features of disseminated carcinomatosis of the bone marrow due to gastric cancer: the pathogenesis of bone destruction. Oncol Rep. 2006;16:735-40.
8. Tokar M, Bobilev D, Ariad S, Geffen DB. Disseminated intravascular coagulation at presentation of advanced gastric cancer. Isr Med Assoc J. 2006;8:853-5.
9. Pyrhönen S, Kuitunen T, Nyandoto P, Kouri M. Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer. Br J Cancer. 1995;71:587-91.
10. Glimelius B, Ekström K, Hoffman K, Graf W, Sjödén PO, Haglund U, et al. Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol. 1997;8:163-8.
11. Kim HS, Yi SY, Jun HJ, Lee J, Park JO, Park YS, et al. Clinical outcome of gastric cancer patients with bone marrow metastases. Oncology. 2007;73:192-7.